|
Building Relationships with Clinical Research Sites
delete
|
Changes and Challenges in Foreign Clinical Research
delete
RECIST 1.0 & 1.1: Overview/Data Challenges in Oncology Clinical Trials
delete
|
Quality Risk Management in Clinical Trials and Pharmacovigilance
delete
|
Regulatory Intelligence
delete
|
Writing and Updating the Investigator's Brochure
delete
|
Monitoring Plan Development
delete
|
Adequate Sponsor Monitoring Systems
delete
|
FDA's BIMO Program: Inspection of Sponsors, CROs, and Monitors
delete
Electronic Source Documentation: Navigating the FDA Draft Guidance
delete
|
Good Clinical Practice: Practical Application and Implementation
delete
|
Informed Consent Content & Process Requirements
delete
|
Real-World Monitoring: Tips for Success and Sanity
delete
|
Collaborating with CROs
delete
|
Principal Investigator Oversight & the Appropriate Delegation of Tasks
delete
|
10-Week Clinical Research Associate (CRA) On-Boarding Program
delete
Implications of New FDA Guideline Risk Based Approach to Monitoring
delete
|
|
Strategies for Remote Monitoring
delete
|
The GCPs of Essential Documents
delete
|
Drug Development and FDA Regulations
delete
GCP Training for Investigators
delete
|
Tools for Trainers: Clinical Research Job-Aids and Checklists
delete
|
Use of Notes to File in Clinical Trial Essential Documentation
delete
Principal Investigator Training: Roles and Responsibilities
delete
|
Trial Master Files: Why They Are Important & How to Organize Workshop
delete
|
Medical Device Development: U.S. and EU Differences
delete
Data Privacy: Global Regulations and Expectations
delete
|
How to Write Effective Monitoring Reports and Communications Workshop
delete
|
Adverse Event Monitoring for CRAs
delete
|
|
|
|
|
|